Asthmalike symptoms following intratracheal exposure of guinea pigs to sulfur mustard aerosol: Therapeutic efficacy of exogenous lung surfactant Curosurf and Salbutamol

Inhalation Toxicology

Volumn 16, Issue 8, 2004, Pages 537-548

  Van Helden, Herman P M ^a   Kuijpers, Willem C ^a   Diemel, Robert V ^b  

^a TNO   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; LUNG SURFACTANT; MUSTARD GAS; PORACTANT; SALBUTAMOL;

ACUTE TOXICITY; ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BOLUS INJECTION; BRONCHOSPASM; CONTROLLED STUDY; DRUG EFFICACY; GUINEA PIG; HISTOLOGY; HUMAN; INFLAMMATION; LD 50; LUNG EDEMA; LUNG LAVAGE; LUNG MINUTE VOLUME; LUNG TOXICITY; MALE; NEBULIZATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SURFACE TENSION; SYMPTOMATOLOGY;

AEROSOLS; ALBUTEROL; ANIMALS; ASTHMA; BIOLOGICAL PRODUCTS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHODILATOR AGENTS; CHEMICAL WARFARE AGENTS; DISEASE MODELS, ANIMAL; GUINEA PIGS; INTUBATION, INTRATRACHEAL; LETHAL DOSE 50; LUNG; MALE; MUSTARD GAS; PHOSPHOLIPIDS; RESPIRATORY FUNCTION TESTS; SPECIFIC PATHOGEN-FREE ORGANISMS; SURFACE TENSION; TRACHEA;

ANIMALIA; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 3142750726     PISSN: 08958378     EISSN: None     Source Type: Journal    
DOI: 10.1080/08958370490442520     Document Type: Article

References (24)

1. Advenier, C., Qian, Y., Koune, J. D., Molimard, M., Candenas, M. L., and Naline, E. 1992. Formoterol and salbutamol inhibit bradikinin- and histamine-induced airway microvascular leakage in guinea pigs. Br. J. Pharmacol. 105(4):792-798.
2. Bergshoff, R. S. 1919. The more common gases: Their effect on the respiratory tract. Observations on two thousand cases. Arch. Int. Med. 24:678-684.
3. Bowring, N. E., Bucle, D. R., Clarke, G. D., Taylor, J. F., and Arch, J. R. 1991. Evaluation of potassium channel activator BRL 38227 as an inhaled bronchodilator in the guinea pig: Contrast with nifedipine and salbutamol. Pulm. Pharmacol. 4(2):99-105.
4. Calabresi, P., and Parks, R. E. 1985. Antiproliferative agents and drugs used for immunosuppression. In The pharmacological basis of therapeutics, eds. H. Goodman and M. Gilman, p. 1247. New York: Macmillan.
5. Cameron, G. R., Gaddum, J. H., and Short, R. H. D 1946. The absorption of war gases by the nose. J. Pathol. Bacteriol. 58:449-455.
6. Calvet, J., Jarreau, P., Levame, M., D'orthe, M., Harf, A., and Macquin-Mavier, I. 1994. Acute and chronic respiratory effects of sulfur mustard intoxication in guinea pigs. J. Appl. Physiol. 76(2):681-688.
7. Calvet, J. H., Coste, A., Levame, M., Harf, A., Macquin-Mavier, I., and Escudier, E. 1996. Airway epithelial damage induced by sulfur mustard in guinea pigs, effects of glucocorticoids. Hum. Exp. Toxicol. 15(12):964-971.
8. Easton, D., Doll, J., and Doll, R. 1988. Cancers of the respiratory tract in mustard gas workers. Br. J. Ind. Med. 45:652-659.
9. Haagsman, H. P. 1992. Toxicological aspects of the surfactant system. Pulmonary surfactant. In Pulmonary surfactant: Frommolecular biology to clinical practice, eds. B. Robertson, L. M. G. Van Golde, and J. J. Batenburg, pp. 705-734. Amsterdam: Elsevier Science.
10. Langenberg, J. P., Van der Schans, G. P., Spruit, H. E. T., Kuijpers, W. C., Mars-Groenendijk, R. H., Dijk-Knijnenburg, H. C. M., Trap, H. C., Van Helden, H. P. M., and Benschop, H. P. 1998. Toxicokinetics of sulfur mustard and its DNA-adducts in the hairless guinea pig. Proceedings BioScience Review, Hunt Valley, MD, 31 May-4 June.
11. Morgenstern, P., Koss, F. R., and Alexander, W. W. 1947. Residual mustard gas bronchitis: Effects of prolonged exposure to low concentrations of mustard gas. Ann. Intern. Med. 26:27-40.
12. National Research Council. 1997. Review of acute human-toxicity estimates for selected chemical warfare agents. pp. 59-66. Washington, DC: National Academy Press. http://books.nap.edu
13. Papirmeister, B., Feister, A. J., Robinson, S. I., and Ford, R. A. 1991. Medical defense against mustard gas. Toxic mechanisms and pharmacological implications. Boca Raton, FL: CRC Press.
14. Pauser, G., Aloy, A., Carvana, M., Graninger, M., Harvel, M., Koller, W., and Mutz, N. 1984. Lethal intoxication by war gasses on Iranian soldiers. In Proceedings of the First World Congress on Biological and Chemical Warfare, Toxicological evaluation, ed. A. Heyndricks, A, p. 341, Ghent: Ghent University Press.
15. Putz, G., Walch, M., Van Eijk, M., and Haagsman, H. P. 1998. A spreading technique for forming film in a captive bubble. Biophys. J. 75:2229-2239.
16. Sandall, T. E. 1922. The later effects of gas poisoning. Lancet 2:857-859.
17. Sohrabpour, H. 1987. Observation and clinical manifestations of patients injured with mustard gas. Med. J. Islam. Repub. Iran 1:32-37.
18. Somani, S. M., and Babu, S. R. 1989. Toxicodynamics of sulfur mustard. Int. J. Clin. Pharm. Ther. Toxicol. 27(9):419-435.
19. Stade, K. 1964. Pharmakologie und Klinik Synthetischer Gifte, p. 130. Berlin: Deutscher Miltarverlag.
20. Van Helden, H. P. M., Kuijpers, W. C., Steenvoorden, D., Go, C., Bruijnzeel, P. L. B., Van Eijk, M., and Haagsman, H. P. 1997. Intratracheal aerosolization of endotoxin (LPS) in the rat: A comprihensive animal model to study adult (acute) respiratory distress syndrome. Exp. Lung Res. 23:297-316.
21. Wheeldon, E. B., Walker, M. E., Murphy, D. J., and Turner, C. R. 1992. Intratracheal aerosolization of endotoxin in the rat: A model for the adult respiratory distress syndrome (ARDS). Lab. Anim. 26:29-37.
22. Willems, J. L. 1989. Clinical management of mustard gas casualties. Ann. Med. Mil. (Belg.) 3(suppl.):161.
23. World Health Organization. 1984, Report of the specialists appointed by the Secretary-General to investigate allegations by the Islamic Republic of Iran concerning the use of chemical weapons. Report S/16433. New York: United Nations, 26 March.
24. World Health Organization. 1986. Report of the mission dispatched by the Secretary-General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq. Report S/17911. New York: United Nations, 12 March.